Skip to content

Other product segments

Multiline
0.2%0.0%
Property
0.1%0.0%
Financial
0%
Health
0%
Specialty
0%

Similar metrics at other companies

SiriusPoint logo
SPNTCasualty — Year 10
0.5%+0.1pp
Arch Capital Group logo
ACGLCasualty — Year Ten
3%-0.4pp
SiriusPoint logo
SPNTCasualty — Year 9
1.7%+1.2pp
Everest Group logo
EGCasualty Insurance — Year ten
7.9%
SiriusPoint logo
SPNTCasualty — Year 8
3.8%+2.7pp
SiriusPoint logo
SPNTCasualty — Year 6
8.9%-68.8pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s casualty — year 10.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s casualty — year 10?
Greenlight Capital RE, Ltd. (GLRE) reported casualty — year 10 of 12.2% in Q4 2025.
What does casualty — year 10 mean?
This metric represents the total revenue or financial activity attributed to the casualty reinsurance segment during the tenth year of the reporting period. It reflects the final year of the observed trend in casualty underwriting performance and premium generation. It is used to evaluate the maturity and long-term sustainability of the company's casualty reinsurance business segment.